Wenzel Spine

Wenzel Spine is a privately-held medical device innovator with a 17+ year history in expandable spinal implant design. The company has achieved commercial status with a portfolio of FDA-cleared devices, including the recently launched panaSIa™ SI Fusion System, which is the first expandable standalone implant for sacroiliac joint fusion. Its mission centers on a 'less is more' philosophy, aiming to reduce surgical hardware, preserve anatomy, and lower overall costs. With over 21,000 devices implanted and 300+ surgeon partners, Wenzel is establishing itself in the competitive spine surgery market.

Design and manufacturing of standalone, expandable spinal implants for minimally invasive fusion procedures, eliminating the need for supplemental fixation.

Wenzel Spine competes in the crowded spinal implants market against giants like Medtronic, Stryker, and Johnson & Johnson. Its differentiation lies in its specialized focus on standalone, expandable devices that enable true MIS procedures without supplemental fixation, a niche not fully addressed by the broad portfolios of larger competitors.